177 related articles for article (PubMed ID: 37978447)
1. A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma.
Yu WM; Li GW; Lou MG; Wu ZY
BMC Gastroenterol; 2023 Nov; 23(1):401. PubMed ID: 37978447
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients.
Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X
Arch Med Sci; 2020; 16(5):1104-1110. PubMed ID: 32863999
[TBL] [Abstract][Full Text] [Related]
3. Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients.
Shan SG; Gao YT; Xu YJ; Huang Y; Zhang Q; Zhai DK; Li JB; Wang FM; Jing X; Du Z; Wang YJ
Hepatol Res; 2013 Nov; 43(11):1199-210. PubMed ID: 23607749
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Li XS; Li JW; Li H; Jiang T
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32255189
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
Ding W; Tan Y; Qian Y; Xue W; Wang Y; Jiang P; Xu X
PLoS One; 2019; 14(10):e0223971. PubMed ID: 31618252
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Qi CY; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():104. PubMed ID: 24548704
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
12. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.
Xue J; Ge P; Wu Y
Clin Exp Med; 2023 Sep; 23(5):1515-1536. PubMed ID: 36342581
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
14. Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis.
Zhang X; Wu LN; Li XQ; Luo X; Liu SW; Zhang L; Nawaz S; Ma LN; Ding XC
BMC Gastroenterol; 2023 Mar; 23(1):85. PubMed ID: 36964524
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
17. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
18. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.
Zhang CH; Xu GL; Jia WD; Ge YS; Li JS; Ma JL; Ren WH
Int J Cancer; 2012 Jun; 130(11):2685-92. PubMed ID: 21780114
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cyclin-dependent kinase subunit 2 (CKS2) in malignant tumours: a meta-analysis and bioinformatic analysis.
Zhang Y; Li Z; Huang Y; Zou B; Xu Y
BMJ Open; 2024 Jan; 14(1):e073887. PubMed ID: 38296306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
